Conduct a two-arm Phase IIIb trial in Kenya and Tanzania to assess safety and immunogenicity of CHIKV vaccine in health adults and adults living with HIV.
Conduct a two-arm Phase IIIb trial in Kenya and Tanzania to assess safety and immunogenicity of CHIKV vaccine in health adults and adults living with HIV.
Conduct a two-arm Phase IIIb trial in Kenya and Tanzania to assess safety and immunogenicity of CHIKV vaccine in health adults and adults living with HIV.
Conduct a two-arm Phase IIIb trial in Kenya and Tanzania to assess safety and immunogenicity of CHIKV vaccine in health adults and adults living with HIV.
Conduct a two-arm Phase IIIb trial in Kenya and Tanzania to assess safety and immunogenicity of CHIKV vaccine in health adults and adults living with HIV.
Conduct a two-arm Phase IIIb trial in Kenya and Tanzania to assess safety and immunogenicity of CHIKV vaccine in health adults and adults living with HIV.
Conduct a two-arm Phase IIIb trial in Kenya and Tanzania to assess safety and immunogenicity of CHIKV vaccine in health adults and adults living with HIV.